• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$4.15 -$0.05 (-1.19%)

REAL-TIME: Last trade at

Targacept , Inc.

NASDAQ:TRGT

This CEO Had to Go

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

Oops, Our Data Weren't That Good

Targacept slides on study revision

1 Dividend to Buy, 1 Dividend to Sell (AZN, XOM)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

UPDATE: Targacept Stops Developing Diabetes Drug; Shares Fall

3 Stocks to Get on Your Watchlist

AstraZeneca's TC-5214 Shelved - Analyst Blog

Targacept's Stock Falls on Failed Depression Drug

AstraZeneca, Targacept Give Up On Antidepressant Drug TC-5214

AstraZeneca Not To Pursue Regulatory Filing For TC-5214

Depressing Clinical Trial News

24/7 Wall St. Closing Bell (ARMH, HOG, UPS, KMI, AAPL, FCFC, JASO, JEF, PATH, TIF, ORCL, KKD, RCON,

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

Here's What This Super-Investor Has Been Buying

Big Failure for Big Pharma

Tomorrow's Monster Stock

Targacept Sees More AstraZeneca Backing On Alzheimer's Drug

The Worst Health Care Stocks of 2011

5 of Last Week's Biggest Losers

Last Week's Biggest Stock Laggards

The Market Just Spanked My Stock!

US Stock Futures: HOT STOCKS TO WATCH

UPDATE: AstraZeneca/Targacept Antidepressant Misses Study Goal

S&P 500's Big Spenders Beat Top Savers in 2011

This $581 Doughnut Hole Costs Drugmakers

Our Top Biotech Stock Idea

AstraZeneca: TC-5214 Well Tolerated, But Didn't Meet Primary Endpoint

Biotech Pops, Drops, and Break-Ups

The 8 Highest Potential Returns in Biotechnology

TRGT Tries Again With Alzheimer's Disease Drug Candidate

The Fastest-Growing Biotech Stocks

Losing Biobucks as Pharma Reshuffles Its Deck

Top 30 Most Oversold and Undervalued Stocks by Analyst Target Price

Top 15 Most Undervalued Biotech Stocks By Analyst Target Price

4 Biotech Companies With a Two-Year Cash Cushion, Being Snapped Up by the Smart Money

Targacept To End Strategic Alliance With Glaxo In May

See More Articles...